Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Maternal Variables Associated With Adherence in Children With Asthma (asthma)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00688792
Recruitment Status : Unknown
Verified May 2008 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : June 3, 2008
Last Update Posted : June 3, 2008
Sponsor:
Information provided by:
Hadassah Medical Organization

Tracking Information
First Submitted Date May 29, 2008
First Posted Date June 3, 2008
Last Update Posted Date June 3, 2008
Study Start Date July 2008
Estimated Primary Completion Date June 2010   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Outcome Measures Not Provided
Original Other Outcome Measures Not Provided
 
Descriptive Information
Brief Title Maternal Variables Associated With Adherence in Children With Asthma
Official Title Reasons for Poor Adherence for Long-Term Preventing Therapy in Children With Asthma
Brief Summary A questionnaire will be used in order to find out the reasons for poor adherence for long-term treatment in children with asthma. The hypotheses is maternal factors including the knowledge that asthma is a chronic disease and fear to administer inhaled steroids are major obstacles for appropriate adherence.
Detailed Description Parents to children aged 2 - 12 years with moderate to severe asthma who need long-term treatment with inhaled steroids will be included in the study. Three weeks after their visit in the clinic, they will be requested to answer a questionnaire by telephone.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Parents to children aged 2 - 12 years with moderate to severe asthma.
Condition Asthma
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: June¬†2,¬†2008)
100
Original Estimated Enrollment Same as current
Estimated Study Completion Date June 2011
Estimated Primary Completion Date June 2010   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Parents to children aged 2 - 12 years with moderate to severe asthma to whom inhaled steroids was described for a period of at least 4 weeks.

Exclusion Criteria:

  • Parents who will not agree to sign the consent form and parents who do not speak and understand the Hebrew language.
Sex/Gender
Sexes Eligible for Study: All
Ages 2 Years to 12 Years   (Child)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT00688792
Other Study ID Numbers asthma1-HMO-CTIL
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Prof. Dan Engelhard, MD, Hadassah Medical Organization
Study Sponsor Hadassah Medical Organization
Collaborators Not Provided
Investigators
Principal Investigator: Dan Engelhard, MD Hadassah Medical Organization
PRS Account Hadassah Medical Organization
Verification Date May 2008